Results 221 to 230 of about 22,989,400 (391)
A universal, reagent‐free strategy is presented for covalently attaching hydrogels to diverse polymeric substrates through reactive oxygen species. The scalable, linker‐free approach enables robust adhesion and broad material compatibility, advancing the fabrication of hybrid solid–hydrogel systems for next‐generation biomedical devices and bioprinting
Masoud Zhianmanesh+8 more
wiley +1 more source
Increase of Intracellular Zinc Levels Rather Than Zinc Influx Inhibits Interleukin-2 Production in Zinc Supplemented Jurkat Cells. [PDF]
Sobernig CM+3 more
europepmc +1 more source
Interleukin 2 activated tumor inhibition in vivo depends on the systemic involvement of host immunoreactivity. [PDF]
G Forni+4 more
openalex +1 more source
AIE‐active tetranuclear Ir(III) complex Ir‐4 as a sonosensitizer/sonocatalyst is formulated into a nanoplatform with an H2S donor. Ir‐4@S‐R NPs achieves combined endogenous NIR chemiluminescence imaging, sonodynamic therapy and release of H2S in situ by a bioorthogonal sonocatalytic reaction in vivo, achieving safe thrombolysis and anti‐inflammatory ...
Zihan Wu+11 more
wiley +1 more source
Decreased gene expression of interleukin 2 receptor subunit γ (CD132) in tissues of patients with Crohn's disease. [PDF]
Andreu-Ballester JC+10 more
europepmc +1 more source
Amelioration of B16F10 melanoma lung metastasis in mice by a combination therapy with indomethacin and interleukin 2. [PDF]
Ranjit S. Parhar, Peeyush K. Lala
openalex +1 more source
Using multivariate analysis, a novel emulgel adjuvant is developed by combining key nanoemulsion formulation variables–hydrogel trapping, small globule size, and mannide monooleate surfactant–achieving 10× greater immunogenicity than MF59 in mice after a single shot.
Ahmed O. Shalash+9 more
wiley +1 more source
Oncolytic adenovirus encoding variant interleukin-2 combined with chemotherapy enables PD-L1 inhibition in pancreatic cancer models. [PDF]
Pakola SA+18 more
europepmc +1 more source